Gene · 800
Papers3,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. | BMJ | 2021 | 33781993 | PubTator, text mining | PubMed |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | Syst Rev | 2021 | 33781348 | PubTator, text mining | PubMed |
| Complete Spontaneous Regression of Lung Metastases after Resection of CIC-Rearranged Sarcoma: A Case Report. | Case Rep Oncol | 2021 | 33776697 | PubTator, text mining | PubMed |
| Anterior Mediastinal Leiomyosarcoma: A Case Report and Literature Review. | Case Rep Oncol | 2021 | 33776690 | PubTator, text mining | PubMed |
| Adamantinoma Presenting With Local Recurrence and Inguinal Lymph Node Metastasis: A Case Report. | Cureus | 2021 | 33763322 | PubTator, text mining | PubMed |
| Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability. | Sci Transl Med | 2021 | 33762435 | PubTator, text mining | PubMed |
| Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy. | Nat Commun | 2021 | 33753741 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids. | Stem Cell Rev Rep | 2021 | 33738695 | PubTator, text mining | PubMed |
| Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication. | Sci Rep | 2021 | 33731721 | PubTator, text mining | PubMed |
| Primary BRAF Mutant Melanoma of the Lung Treated with Immunotherapy and Pulmonary Bilobectomy: A Case Report. | Am J Case Rep | 2021 | 33731665 | PubTator, text mining | PubMed |
| Inoperable Left Renal Vein Leiomyosarcoma Refractory to Chemotherapy Invades Inferior Vena Cava and Right Atrium: A Case Report. | Cureus | 2021 | 33717726 | PubTator, text mining | PubMed |
| RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site? | Genes Chromosomes Cancer | 2021 | 33715240 | PubTator, text mining | PubMed |
| Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer. | Nat Commun | 2021 | 33712615 | PubTator, text mining | PubMed |
| Caldesmon: Biochemical and Clinical Implications in Cancer. | Front Cell Dev Biol | 2021 | 33681215 | PubTator, text mining | PubMed |
| Intravenous Leiomyosarcoma of the Lower Extremity: As Peripheral as It Gets. | Cureus | 2021 | 33680615 | PubTator, text mining | PubMed |
| Primary vulvar leiomyosarcoma localized in the Bartholin's gland area: A case report and review. | Mol Clin Oncol | 2021 | 33680460 | PubTator, text mining | PubMed |
| Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma. | Front Immunol | 2021 | 33679756 | PubTator, text mining | PubMed |
| The CAD risk locus 9p21 increases the risk of vascular calcification in an iPSC-derived VSMC model. | Stem Cell Res Ther | 2021 | 33676559 | PubTator, text mining | PubMed |
| High Throughput Proteomic Exploration of Hypothermic Preservation Reveals Active Processes within the Cell Associated with Cold Ischemia Kinetic. | Int J Mol Sci | 2021 | 33673561 | PubTator, text mining | PubMed |
| Inflammatory Undifferentiated Pleomorphic Sarcoma Mimicking Bacteremia in an Elderly Patient: A Case Report. | Medicina (Kaunas) | 2021 | 33670681 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/800/papers?page=55